Combination vs. Monotherapy for Stenotrophomonas Maltophilia Infections
Condition(s) studied
Study summary
The goal of this multicentre observational study is to analyse the treatment strategies and the outcomes for patients with S. maltophilia infections using target trial emulation methodology. The main question it aims to answer is:
• Does combined therapy achieve better results than monotherapy in treating S. maltophilia infections?
Researchers will compare groups receiving monotherapy and combined therapy to see if there are differences in all-cause 30-day mortality.
Eligibility
Primary outcome measure(s)
- All-cause mortality — At 30 days
- All-cause mortality — At 60 days
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Microbiology and Infectious Disease Department, Hospital General Universitario Gregorio Marañón | Madrid | Madrid | Recruiting |
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07593547 on ClinicalTrials.gov ↗ ← All trials in Spain